Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Sequential tumor biopsies in early phase clinical trials of anticancer agents for pharmacodynamic evaluationA Dowlati, J Haaga, S C Remick, et al.Cancer Research|April 1, 1989
Methotrexate and dipyridamole combination chemotherapy based upon inhibition of nucleoside salvage in humansJ K Willson, P H Fischer, S C Remick, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Phase I clinical and pharmacokinetic study of rebeccamycin analog NSC 655649 given daily for five consecutive daysA Dowlati, C L Hoppel, S T Ingalls, et al.Cancer Chemotherapy and Pharmacology|March 28, 2001
Phase II and pharmacokinetic/pharmacodynamic trial of sequential topoisomerase I and II inhibition with topotecan and etoposide in advanced non-small-cell lung cancerA Dowlati, N Levitan, N H Gordon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Novel oral combination chemotherapy in the treatment of intermediate-grade and high-grade AIDS-related non-Hodgkin's lymphomaS C Remick, J J McSharry, B C Wolf, et al.Drugs|March 11, 2000
Oral combination chemotherapy in the management of AIDS-related lymphoproliferative malignanciesS C Remick, N Sedransk, R Haase, et al.Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|May 1, 1995
Practice effects with the NIMH AIDS abbreviated neuropsychological batteryR J McCaffrey, J P Cousins, H J Westervelt, et al.Cancer Research|November 15, 1989
Phase I trial of hepatic artery infusion of 5-iodo-2'-deoxyuridine and 5-fluorouracil in patients with advanced hepatic malignancy: biochemically based combination chemotherapyS C Remick, A B Benson, J L Weese, et al.Cancer Research|May 1, 1990
Phase I trial of 5-fluorouracil and dipyridamole administered by seventy-two-hour concurrent continuous infusionS C Remick, J L Grem, P H Fischer, et al.Journal of Clinical Microbiology|October 1, 1996
Prevalence of human herpesvirus 8 DNA sequences in several patient populationsC C Marchioli, J L Love, L Z Abbott, et al.Pageof 5